A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer
This study has been completed.
Sponsor:
Pfizer
Information provided by:
Pfizer
ClinicalTrials.gov Identifier:
NCT00051051
First received: January 2, 2003
Last updated: May 3, 2007
Last verified: September 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2005 |
| Estimated Primary Completion Date: | No date given |